previous compound ID: 2932 next compound
InChIKey: INVTYAOGFAGBOE-UHFFFAOYSA-N
SMILES: C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3

biological descriptors:

CFTR relevance: CFTR corrector

Category:
Influence on CFTR function enhances CFTR function
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 61
"DM Hutt" "EJ Sorscher" "T Okiyoneda" "RA Frizzell" "B Hoch" "S Noel" "Y Matsumura" "JM Gottesfeld" "JR Riordan" "JW Kelly" "M Gentzsch" "D Herman" "GL Lukacs" "AP Rodrigues" "A Schmidt" "J Matteson" "JM Pilewski" "PJ Thomas" "WR Skach" "G Manning" "WE Balch" "JR_3rd Yates" "W Kellner"

chemical graph of compound 2932





CID is 4261
synonyms found at PubChem are:
Entinostat, ms-275, 209783-80-2, SNDX-275, MS 275, MS-27-275, SNDX 275, MS 27-275, Histone Deacetylase Inhibitor I, Entinostat (USAN/INN), Entinostat (MS-275), UNII-1ZNY4FKK9H, 1ZNY4FKK9H, CHEMBL27759, pyridin-3-ylmethyl 4-((2-aminophenyl)carbamoyl)benzylcarbamate, pyridin-3-ylmethyl {4-[(2-aminophenyl)carbamoyl]benzyl}carbamate, INVTYAOGFAGBOE-UHFFFAOYSA-N, MS275, N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide, pyridin-3-ylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate, Entinostat (MS-275,SNDX-275), IN1470, NSC706995, BAY86-5274, NSC-706995, BAY 86-5274, pyridin-3-ylmethyl 4-(2-aminophenylcarbamoyl)benzylcarbamate, pyridin-3-ylmethyl{4-[(2-aminophenyl)carbamoyl]benzyl}carbamate, 3-Pyridinylmethyl ((4-(((2-aminophenyl)amino)carbonyl)phenyl)methyl)carbamate, Carbamic acid, ((4-(((2-aminophenyl)amino)carbonyl)phenyl)methyl)-, 3-pyridinylmethyl ester, W-201831, 3-pyridylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate, N-(2-Aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl)aminomethyl]benzamide, pyridin-3-ylmethyl N-({4-[(2-aminophenyl)carbamoyl]phenyl}methyl)carbamate, Carbamic acid, [[4-[[(2-aminophenyl)carbaonyl]phenyl]methyl]-, 3-pyridinylmethyl ester, N-[[4-[(2-aminoanilino)-oxomethyl]phenyl]methyl]carbamic acid 3-pyridinylmethyl ester, 442532-99-2, entinostatum, pyridin-3-ylmethyl (4-((2-aminophenyl)carbamoyl)benzyl)carbamate, N-(2-aminophenyl)-4-[N-(pyridin-3-ylmethoxycarbonyl)aminomethyl]benzamide, 3-pyridinylmethyl [[4-[[(2-aminophenyl)amino]carbonyl]phenyl]methyl]carbamate, PubChem24433, AC1L1HRM, AC1Q5NOI, Entinostat [USAN:INN], MS-275 (Entinostat), MS-275 - Entinostat, D0M8FD, benzamide-type inhibitor, 3, MLS006010183, SCHEMBL148309, GTPL7007, DTXSID0041068, BDBM19410, CTK8F0220, AOB2570, EX-A038, SYN3039, CHEBI:132082, MolPort-005-942-713, BCPP000155, HMS3648K12, HMS3654O11, ACT06782, BCP01824, MS-275,Entinostat,SNDX-275/, ZINC1488870, ABP000145, BN0881, GP3697, s1053, AKOS024262667, AC-8968, AN-1299, BCP9000967, Carbamic acid, 3-pyridinylmethyl ester, CCG-208680, CS-0511, DB11841, Entinostat (MS-275, SNDX-275), RL02591, KS-0000063I, NCGC00165833-01, NCGC00165833-02, NCGC00165833-03, NCGC00165833-04, NCGC00165833-13, AJ-26331, AK158952, AS-17906, BC654076, HY-12163, KB-55107, MS27-275, NCI60_038022, SMR004458705, MS-275, A HDAC1 and HDAC3 inhibitor, AB0021206, AX8140473, KB-302728, LS-185285, RT-013958, ST2406823, FT-0667871, V2451, D09338, W-5370, 48247-EP2298768A1, 48247-EP2305643A1, 48247-EP2308868A1, 48247-EP2311494A1, 48247-EP2311840A1, 783M802, A815057, MS-275,Entinostat, SNDX-275, MS-27-275, SR-01000946382, Entinostat, SNDX-275, MS-27-275, MS-275, SR-01000946382-1, BRD-K77908580-001-02-1, BRD-K77908580-001-04-7, (pyridin-3-yl)methyl 4-(2-aminophenylcarbamoyl)benzylcarbamate, [4-(2-Amino-phenylcarbamoyl)-benzyl]-carbamic acid pyridin-3-ylmethyl ester, N-[[4-[[(2-Aminophenyl)amino]carbonyl]phenyl]methyl]-3-pyridinylmethyl ester, carbamic acid, Carbamic acid, [[4-[[(2-aminophenyl)amino]carbonyl]phenyl] methyl]-, 3-pyridinylmethyl ester